In addition, a meta-analysis of 16 ovarian cancer cell lines and ovarian tumors suggested a significantly elevated APLNR expression that is correlated with poor prognosis in patients with serous ovarian cancer [48]. Here, APLNR is linked to ovarian serous adenocarcinoma.